Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Management of Atrial Fibrillation with RVR in Sepsis with Hypotension

Immediate Management Strategy

  • The American College of Cardiology recommends intravenous amiodarone as the first-line agent for acute rate control in patients with atrial fibrillation and rapid ventricular response (RVR) who have severe left ventricular dysfunction, heart failure, or hemodynamic instability, where beta-blockers and calcium channel blockers are contraindicated 1, 2
  • Amiodarone is specifically recommended for patients with AF and RVR who have severe LV dysfunction, heart failure, or hemodynamic instability, with a loading dose of 150 mg IV over 10 minutes, which may be repeated in 10-30 minutes if necessary 1, 2, 3

Alternative Agents

  • The American College of Cardiology recommends digoxin as an alternative for acute rate control in patients with heart failure or hemodynamic instability when other measures are unsuccessful or contraindicated 1, 2, 4
  • Combination therapy with digoxin and amiodarone is reasonable to control both resting and exercise heart rate 1, 2, 4

Critical Pitfalls to Avoid

  • The American Heart Association advises against using nondihydropyridine calcium channel blockers (diltiazem, verapamil) in patients with decompensated heart failure or significant hypotension 1, 2, 3
  • The American College of Cardiology recommends against using beta-blockers initially in hypotensive patients, as they can worsen hemodynamic compromise 3

Long-Term Considerations

  • The American College of Cardiology suggests considering cardiology follow-up for rhythm management strategy after acute illness resolves 3